Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Antonello Quadri"'
Autor:
Daniela Di Mauro, Andrea D'Alessio, Davide Resta, Carmelo Fortugno, Simonetta Villa, Luca Geroli, S. Cecchini, Antonello Quadri
Publikováno v:
Tumori Journal. 102:S65-S68
Purpose Cetuximab and panitumumab are monoclonal antibody inhibitors that bind the epidermal growth factor receptor (EGFR) currently used in the treatment of metastatic colorectal cancer. The main adverse event related to EGFR inhibitors (EGFR-Is) is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2eba71793a3d621c5f83af0db0226f
https://doi.org/10.5301/tj.5000579
https://doi.org/10.5301/tj.5000579
Autor:
Roberto Labianca, Giordano D. Beretta, Basem Kildani, Laura Milesi, Federica Merlin, Stefania Mosconi, M. Adelaide Pessi, Tiziana Prochilo, Antonello Quadri, Gemma Gatta, Filippo de Braud, Jacques Wils
Publikováno v:
Critical Reviews in Oncology/Hematology. 74:106-133
Colon cancer is one of the leading tumours in the world and it is considered among the big killers, together with lung, prostate and breast cancer. In the recent years very important advances occurred in the field of treatment of this frequent diseas
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47483a64141489aa6deb6f9c5e7ab3f2
https://doi.org/10.1016/j.critrevonc.2010.01.010
https://doi.org/10.1016/j.critrevonc.2010.01.010
Autor:
Maria Spinthouri, Renoto Ciotti, Antonello Quadri, Roberto Labianca, Lycurgus Liaropoulos, Ana Ortega, George Dranitsaris, Pauline Leung
Publikováno v:
Scopus-Elsevier
The neurokinin-1 (NK1) receptor antagonists are a new class of agents designed to reduce the risk of emesis following chemotherapy, particularly with cisplatin. Early data from double-blind randomised trials suggest that an orally administered NK1 an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5cafcb418b714964c9a972461d9d4b3e
https://doi.org/10.2165/00019053-200119090-00007
https://doi.org/10.2165/00019053-200119090-00007
Autor:
Mario, Scartozzi, Italo, Bearzi, Alessandra, Mandolesi, Eva, Galizia, Chiara, Pierantoni, Fotios, Loupakis, Rossana, Berardi, Alberto, Zaniboni, Antonello, Quadri, Fausto, Zorzi, Simona, Biagetti, Cristian, Loretelli, Tommasina, Biscotti, Roberto, Labianca, Gianluca, Masi, Alfredo, Falcone, Stefano, Cascinu
Publikováno v:
Analytical and quantitative cytology and histology. 31(6)
To clarify the role of epidermal growth factor receptor (EGFR) promoter methylation in primary colorectal cancers and corresponding metastases and its relationship to EGFR expression.Formalin-fixed tumor samples (primary site and metastasis)from colo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::130b4d7f8f2f9cdf97b462dadd103b68
https://pubmed.ncbi.nlm.nih.gov/20698358
https://pubmed.ncbi.nlm.nih.gov/20698358
Autor:
Antonello Quadri, Chiara Pierantoni, Gianluca Masi, Fotios Loupakis, Eva Galizia, Fausto Zorzi, Stefano Cascinu, Francesca Negri, Alberto Zaniboni, Rossana Berardi, Tommasina Biscotti, Roberto Labianca, Alessandra Mandolesi, Alfredo Falcone, Italo Bearzi, Mario Scartozzi
Publikováno v:
BMC Cancer, Vol 9, Iss 1, p 303 (2009)
BMC Cancer
BMC Cancer
Background K-RAS wild type colorectal tumors show an improved response rate to anti-EGFR monoclonal antibodies. Nevertheless 70% to 40% of these patients still does not seem to benefit from this therapeutic approach. FISH EGFR GCN has been previously
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::24ffaf484ac2676b73185339c5d03ef6
http://www.biomedcentral.com/1471-2407/9/303
http://www.biomedcentral.com/1471-2407/9/303
Colorectal cancer is the second most common type of cancer in industrialized countries. Despite improved resection procedures and optimized adjuvant chemotherapy, local or distant recurrences occur in 22-25% of patients with stage II/III colon cancer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4fe0f0d35330fefa35c80c54a37c71c9
http://hdl.handle.net/11391/1480908
http://hdl.handle.net/11391/1480908
Publikováno v:
European Oncology & Haematology. :79
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7dd967f91d36842be48718a1a0f4159e
https://doi.org/10.17925/eoh.2008.04.2.79
https://doi.org/10.17925/eoh.2008.04.2.79
Autor:
Alessandra Mandolesi, Tommasina Biscotti, Alfredo Falcone, Italo Bearzi, Alberto Zaniboni, Rossana Berardi, Antonello Quadri, Mario Scartozzi, Roberto Labianca, Vincenzo Catalano, Fausto Zorzi, Fotios Loupakis, Chiara Pierantoni, Stefano Cascinu
Publikováno v:
Università di Pisa-IRIS
Purpose NF-kB expression has been shown to be responsible for resistance to antineoplastic agents and it also plays a part in the activation of the epidermal growth factor receptor downstream signaling pathway in colorectal tumors. The aim of our ana
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::17768c0fc24d3077f5e73586b070cf5e
https://arpi.unipi.it/handle/11568/115208
https://arpi.unipi.it/handle/11568/115208
Publikováno v:
BMC Cancer. 2009, Vol. 9, p303-310. 8p.
Autor:
Gridelli, Cesare, Perrone, Francesco, Gallo, Ciro, Cigolari, Silvio, Rossi, Antonio, Piantedosi, Francovito, Barbera, Santi, Ferraù, Francesco, Piazza, Elena, Rosetti, Francesco, Clerici, Maurizia, Bertetto, Oscar, Robbiati, Sergio Federico, Frontini, Luciano, Sacco, Cosimo, Castiglione, Federico, Favaretto, Adolfo, Novello, Silvia, Migliorino, Maria Rita
Publikováno v:
JNCI: Journal of the National Cancer Institute; 3/5/2003, Vol. 95 Issue 5, p362, 11p, 1 Diagram, 4 Charts, 2 Graphs